Basic information

Biomarker: HLDF factor

Histology type: endometrial carcinoma

Cohort characteristics

Followed up time :

Total number Group I Group I number Group II Group II number Group III Group III number Group IV Group IV number

Sample information

Conclusion: Antibodies to the HLDF factor may be used as a new immunohistochemical marker for the differential diagnosis of benign and malignant endometrial processes.

Sample type : tissue

Sample method: immunohistochemistry

Expression pattern : Antibodies to the HLDF factor

Disease information

Related information

UniProt Link:

Molecular function from UniProt:

Visulization